IDH1 and central nervous system cancer: This discovery was initially made following the finding of gain of function mutations in genes encoding both the cytoplasmic and mitochondrial isoforms of isocitrate dehydrogenase (IDH1 and IDH2, respectively) in high‐grade gliomas and glioblastomas.